The place of oxycodone/naloxone in chronic pain management.

about

Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxone Evolving paradigms in the treatment of opioid-induced bowel dysfunction Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction

P2860

Q26766416-52B314C3-D464-4660-962A-95F1FBA0B342 Q26777692-8575D836-B868-4AB4-8479-5B54C77DCBAA Q26995944-D3AD5B73-8888-4DE2-B717-D31F756A70F0

P2860

The place of oxycodone/naloxone in chronic pain management.

Item

http://www.wikidata.org/entity/Q42161578

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The place of oxycodone/naloxone in chronic pain management.

@en

The place of oxycodone/naloxone in chronic pain management.

@nl

type

Item

label

The place of oxycodone/naloxone in chronic pain management.

@en

The place of oxycodone/naloxone in chronic pain management.

@nl

prefLabel

The place of oxycodone/naloxone in chronic pain management.

@en

The place of oxycodone/naloxone in chronic pain management.

@nl

P1476

The place of oxycodone/naloxone in chronic pain management.

@en

P2093

Wojciech Leppert

http://www.w3.org/2001/XMLSchema#string

P2860

Morphine and alternative opioids in cancer pain: the EAPC recommendations

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.

Adjuvant analgesics in cancer pain management.

Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.

Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Oxycodone: a review of its use in the management of pain.

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

Interventional therapies for cancer pain management: important adjuvants to systemic analgesics.

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2013.34614

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240310300

http://www.w3.org/2001/XMLSchema#string

P698

23788978

http://www.w3.org/2001/XMLSchema#string

P921

chronic pain

pain management

P932

3685363

http://www.w3.org/2001/XMLSchema#string

The place of oxycodone/naloxone in chronic pain management.

about

P2860

P2860

The place of oxycodone/naloxone in chronic pain management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932